Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation criteria as searches for non-prescription metabolic wellness patches ...
ATRIMED today shared an update on a long running research effort led in part by physician scientist Dr. Latha Damle, whose work alongside her husband and research partner, Dr. Damle, has helped build ...
Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
In this GEN webinar, our expert speakers will show how Nanoworx combines technical expertise with scalable workflows to support the seamless development of nanomedicines from early discovery and ...
Tomer Izraeli, CEO of Polyrizon, commented, "Selecting NASARIX™ as the brand name for PL-14 allergy blocker reflects our commitment to commercial readiness and our focus on building a strong and ...
In return for $10 million upfront, Foresee sold the global rights for its MMP-12 inhibitor programs to Primevera Therapeutics ...
Octapharma has received approval from the US Food and Drug Administration (FDA) for a new 2-gram (g) formulation of Fibryga ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...
WASHINGTON — Federal health officials are unilaterally reducing the number of recommended pediatric immunizations in response ...
4d
Pharmaceutical Isolator Market Size to Reach USD 509 Million by 2031 | CAGR 2.4% - Valuates Reports
Pharmaceutical Isolator Market SizeThe global Pharmaceutical Isolator market was valued at USD 432 Million in the year 2024 and is projected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback